$266 Thousand is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 52 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 89.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BBRE | Sell | JPM BETABLDRS MSCI US REITetfs | $206,920 | -99.9% | 2,535,789 | -6.4% | 77.88% | -2.1% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $5,879 | -99.9% | 29,919 | -39.9% | 2.21% | -47.3% |
| XOM | Sell | EXXON MOBIL CORP | $313 | -100.0% | 2,837 | -74.2% | 0.12% | -67.2% |
| MUFG | Exit | MITSUBISHI UFJ FINL GRP INC | $0 | – | -167 | -100.0% | 0.00% | – |
| UBS | Exit | UBS GROUP AG | $0 | – | -67 | -100.0% | 0.00% | – |
| KOF | Exit | COCA-COLA FEMSA SAB-SP ADR | $0 | – | -14 | -100.0% | 0.00% | – |
| PBRA | Exit | PETROLEO BRASIL SP PREF ADRnot used | $0 | – | -83 | -100.0% | 0.00% | – |
| AEG | Exit | AEGON N.V.-AMERICAN REG ADR | $0 | – | -136 | -100.0% | 0.00% | – |
| BABA | Exit | ALIBABA GROUP HOLDING LTD | $0 | – | -8 | -100.0% | 0.00% | – |
| ERJ | Exit | EMBRAER SA | $0 | – | -90 | -100.0% | 0.00% | – |
| UL | Exit | UNILEVER N.V. | $0 | – | -16 | -100.0% | 0.00% | – |
| BUD | Exit | ANHEUSER-BUSCH INBEV SA/NV | $0 | – | -13 | -100.0% | 0.00% | – |
| HMC | Exit | HONDA MOTOR CO LTD (ADR) | $0 | – | -25 | -100.0% | 0.00% | – |
| ENIC | Exit | ENEL CHILE SA-ADR | $0 | – | -423 | -100.0% | 0.00% | – |
| NVS | Exit | NOVARTIS AG | $0 | – | -14 | -100.0% | 0.00% | – |
| ABEV | Exit | AMBEV SA | $0 | – | -231 | -100.0% | 0.00% | – |
| E | Exit | ENI S P A | $0 | – | -25 | -100.0% | 0.00% | – |
| WPP | Exit | WPP PLC NEW/ADRnot used | $0 | – | -15 | -100.0% | 0.00% | – |
| TTE | Exit | TOTAL SA-SPON ADR | $0 | – | -14 | -100.0% | 0.00% | – |
| Exit | GSK PLC-SPON ADR | $0 | – | -29 | -100.0% | 0.00% | – | |
| GRFS | Exit | GRIFOLS SA-ADR | $0 | – | -107 | -100.0% | 0.00% | – |
| SNY | Exit | SANOFI-AVENTIS | $0 | – | -23 | -100.0% | 0.00% | – |
| SAP | Exit | SAP SE SHS | $0 | – | -7 | -100.0% | 0.00% | – |
| ORAN | Exit | ORANGE SPON ADR | $0 | – | -91 | -100.0% | 0.00% | – |
| CS | Exit | CREDIT SUISSE GP SP ADR | $0 | – | -168 | -100.0% | 0.00% | – |
| TAK | Exit | TAKEDA PHARMACEUTIC | $0 | – | -137 | -100.0% | -0.00% | – |
| GOOG | Exit | ALPHABET INC | $0 | – | -5,350 | -100.0% | -0.19% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -130,409 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
| 3 | 2023-06-02 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.